ENTA

ENTA Change in Working Capital

$4.97MTTM · USD

Period ending:

ENTA FY Change in Working CapitalUSD
ENTA FY Change in Working Capital2010-09-30: -$18.41M2011-09-30: -$2.40M2012-09-30: $93.00K2013-09-30: $741.00K2014-09-30: -$2.26M2015-09-30: -$16.83M2016-09-30: $6.17M2017-09-30: $21.97M2018-09-30: -$61.79M2019-09-30: $11.49M2020-09-30: $12.90M2021-09-30: -$13.69M2022-09-30: $6.79M2023-09-30: $8.02M2024-09-30: $7.13M2025-09-30: $39.91M$39.91M-$61.79M
2010-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ENTA change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 16 observations from Sep 30, 2010 to Sep 30, 2025.

Enanta Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
39,909,000
7,130,000
8,024,000
6,789,000
-13,688,000
12,900,000
11,491,000
-61,787,000
21,970,000
6,171,000
-16,830,000
-2,258,000
741,000
93,000
-2,400,000
-18,411,000

Compare change in working capital

All ENTA financial metrics · ENTA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.